Show simple item record

dc.contributor.authorMoore, Constance M.
dc.contributor.authorFrazier, Jean A.
dc.contributor.authorGlod, Carol A.
dc.contributor.authorBreeze, Janis L.
dc.contributor.authorDieterich, Megan E.
dc.contributor.authorFinn, Chelsea T.
dc.contributor.authorFrederick, Blaise Deb
dc.contributor.authorRenshaw, Perry F.
dc.date2022-08-11T08:10:27.000
dc.date.accessioned2022-08-23T17:09:41Z
dc.date.available2022-08-23T17:09:41Z
dc.date.issued2007-04-11
dc.date.submitted2011-02-10
dc.identifier.citationJ Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):524-34. <a href="http://dx.doi.org/10.1097/chi.0b013e31802f5f2c">Link to article on publisher's site</a>
dc.identifier.issn0890-8567 (Linking)
dc.identifier.doi10.1097/chi.0b013e31802f5f2c
dc.identifier.pmid17420688
dc.identifier.urihttp://hdl.handle.net/20.500.14038/45879
dc.description.abstractOBJECTIVE: The purpose of this study was to use proton magnetic resonance spectroscopy, at 4.0 T, to explore the glutamine and glutamate levels in the anterior cingulate cortex of children and adolescents with bipolar disorder (BPD; medicated and unmedicated) and healthy comparison subjects (HCSs). We hypothesized that unmedicated children with BPD would have reduced glutamine and glutamate levels compared with HCSs and medicated children with BPD. METHOD: Spectra were acquired from the anterior cingulate cortex in 22 children and adolescents with DSM-IV-TR BPD, type 1 (13 female: age 12.6 +/- 4.4 years: 7 of the subjects with BPD were unmedicated at the time of the scan) and 10 HCSs (7 female: age 12.3 +/- 2.5 years). RESULTS: Unmedicated subjects with BPD had significantly lower glutamine levels than HCSs or medicated subjects with BPD. There were no differences in glutamate levels between the three groups. CONCLUSIONS: These results are consistent with there being an abnormality in anterior cingulate cortex glia in untreated children and adolescents with BPD. The results of this pilot study may be important in helping us better understand the pathophysiology of child and adolescent BPD. In addition, this observation may help to develop better and more targeted treatments, in particular those affecting the metabolism of glutamine, perhaps by regulation of glutamine synthetase activity.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=17420688&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1097/chi.0b013e31802f5f2c
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAnalysis of Variance
dc.subjectBipolar Disorder
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectFemale
dc.subjectGlutamic Acid
dc.subjectGlutamine
dc.subjectGyrus Cinguli
dc.subjectHumans
dc.subjectMagnetic Resonance Spectroscopy
dc.subjectMale
dc.subjectNeuroglia
dc.subjectOccipital Lobe
dc.subjectProtons
dc.subjectPsychotropic Drugs
dc.subjectPsychiatry
dc.titleGlutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex
dc.typeJournal Article
dc.source.journaltitleJournal of the American Academy of Child and Adolescent Psychiatry
dc.source.volume46
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/psych_pp/407
dc.identifier.contextkey1775347
html.description.abstract<p>OBJECTIVE: The purpose of this study was to use proton magnetic resonance spectroscopy, at 4.0 T, to explore the glutamine and glutamate levels in the anterior cingulate cortex of children and adolescents with bipolar disorder (BPD; medicated and unmedicated) and healthy comparison subjects (HCSs). We hypothesized that unmedicated children with BPD would have reduced glutamine and glutamate levels compared with HCSs and medicated children with BPD.</p> <p>METHOD: Spectra were acquired from the anterior cingulate cortex in 22 children and adolescents with DSM-IV-TR BPD, type 1 (13 female: age 12.6 +/- 4.4 years: 7 of the subjects with BPD were unmedicated at the time of the scan) and 10 HCSs (7 female: age 12.3 +/- 2.5 years).</p> <p>RESULTS: Unmedicated subjects with BPD had significantly lower glutamine levels than HCSs or medicated subjects with BPD. There were no differences in glutamate levels between the three groups.</p> <p>CONCLUSIONS: These results are consistent with there being an abnormality in anterior cingulate cortex glia in untreated children and adolescents with BPD. The results of this pilot study may be important in helping us better understand the pathophysiology of child and adolescent BPD. In addition, this observation may help to develop better and more targeted treatments, in particular those affecting the metabolism of glutamine, perhaps by regulation of glutamine synthetase activity.</p>
dc.identifier.submissionpathpsych_pp/407
dc.contributor.departmentDepartment of Psychiatry
dc.source.pages524-34


This item appears in the following Collection(s)

Show simple item record